Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,998 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

NCT05458297

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +21 more
Locations
  • Alaska Oncology and Hematology ( Site 0037) Anchorage, Alaska, United States
  • Banner MD Anderson Cancer Center ( Site 0040) Gilbert, Arizona, United States
  • Banner MD Anderson Cancer Center - University Medical Center Phoenix-Medical Oncology ( Site 0036) Phoenix, Arizona, United States
  • University of Colorado Anschutz Medical Campus-The Center for Cancer and Blood Disorders ( Site 0008) Aurora, Colorado, United States
View all 108 locations
View Trial Details
Active, not recruiting

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

NCT04013685

Conditions
Acute Leukemia, Acute Lymphoid Leukemia, Acute Myeloid Leukemia, +31 more
Locations
  • City of Hope Duarte, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Stanford Health Care Stanford, California, United States
View all 21 locations
View Trial Details
Active, not recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

NCT06667687

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • Carolina BioOncology Institute /ID# 265259 Huntersville, North Carolina, United States
  • Willamette Valley Cancer Institute and Research Center /ID# 270945 Eugene, Oregon, United States
  • Texas Oncology - Central/South Texas /ID# 270946 Austin, Texas, United States
  • START Mountain Region /ID# 267592 West Valley City, Utah, United States
View all 14 locations
View Trial Details
Active, not recruiting

Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma

NCT03502733

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • UT MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, not recruiting

A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma

NCT05675449

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Clinical Research Advisors (Encino Satellite Location) Encino, California, United States
  • Clinical Research Advisors (Korea Town Satellite Location) Los Angeles, California, United States
View all 36 locations
View Trial Details

Related conditions